161 related articles for article (PubMed ID: 26307963)
1. The Influence of Sesquiterpenes from Myrica rubra on the Antiproliferative and Pro-Oxidative Effects of Doxorubicin and Its Accumulation in Cancer Cells.
Ambrož M; Boušová I; Skarka A; Hanušová V; Králová V; Matoušková P; Szotáková B; Skálová L
Molecules; 2015 Aug; 20(8):15343-58. PubMed ID: 26307963
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell Lines.
Ambrož M; Matoušková P; Skarka A; Zajdlová M; Žáková K; Skálová L
Molecules; 2017 Jun; 22(6):. PubMed ID: 28632185
[TBL] [Abstract][Full Text] [Related]
3. Essential Oil from Myrica rubra Leaves Potentiated Antiproliferative and Prooxidative Effect of Doxorubicin and its Accumulation in Intestinal Cancer Cells.
Ambrož M; Hanušová V; Skarka A; Boušová I; Králová V; Langhasová L; Skálová L
Planta Med; 2016 Jan; 82(1-2):89-96. PubMed ID: 26485638
[TBL] [Abstract][Full Text] [Related]
4. The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice.
Hanušová V; Caltová K; Svobodová H; Ambrož M; Skarka A; Murínová N; Králová V; Tomšík P; Skálová L
Biomed Pharmacother; 2017 Nov; 95():828-836. PubMed ID: 28903178
[TBL] [Abstract][Full Text] [Related]
5. Sesquiterpenes α-humulene and β-caryophyllene oxide enhance the efficacy of 5-fluorouracil and oxaliplatin in colon cancer cells.
Ambrož M; Šmatová M; Šadibolová M; Pospíšilová E; Hadravská P; Kašparová M; Skarková VH; Králová V; Skálová L
Acta Pharm; 2019 Mar; 69(1):121-128. PubMed ID: 31259712
[TBL] [Abstract][Full Text] [Related]
6. Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro.
Rudolfová P; Hanušová V; Skálová L; Bártíková H; Matoušková P; Boušová I
Acta Pharm; 2014 Jun; 64(2):199-209. PubMed ID: 24914720
[TBL] [Abstract][Full Text] [Related]
7. The influence of oracin on reduction and toxicity of doxorubicin in hepatocytes and mammary epithelial cells MCF-10A.
Hanušová V; Boušová I; Pakostová A; Skálová L
Xenobiotica; 2012 Jun; 42(6):571-9. PubMed ID: 22217270
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effects of β-caryophyllene, β-caryophyllene oxide and α-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro.
Nguyen LT; Myslivečková Z; Szotáková B; Špičáková A; Lněničková K; Ambrož M; Kubíček V; Krasulová K; Anzenbacher P; Skálová L
Chem Biol Interact; 2017 Dec; 278():123-128. PubMed ID: 29074051
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitizing Properties of β-Caryophyllene and β-Caryophyllene Oxide in Combination with Doxorubicin in Human Cancer Cells.
DI Giacomo S; DI Sotto A; Mazzanti G; Wink M
Anticancer Res; 2017 Mar; 37(3):1191-1196. PubMed ID: 28314281
[TBL] [Abstract][Full Text] [Related]
10. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the antioxidant and antiproliferative effects of sesquiterpenic compounds in in vitro Caco-2 cell models.
Vinholes J; Gonçalves P; Martel F; Coimbra MA; Rocha SM
Food Chem; 2014 Aug; 156():204-11. PubMed ID: 24629959
[TBL] [Abstract][Full Text] [Related]
12. Potentiating effect of beta-caryophyllene on anticancer activity of alpha-humulene, isocaryophyllene and paclitaxel.
Legault J; Pichette A
J Pharm Pharmacol; 2007 Dec; 59(12):1643-7. PubMed ID: 18053325
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin induces ceramide and diacylglycerol accumulation in rat hepatocytes through independent routes.
Martínez R; Navarro R; Lacort M; Ruiz-Sanz JI; Ruiz-Larrea MB
Toxicol Lett; 2009 Oct; 190(1):86-90. PubMed ID: 19607893
[TBL] [Abstract][Full Text] [Related]
14. Safety assessment, biological effects, and mechanisms of Myrica rubra fruit extract for anti-melanogenesis, anti-oxidation, and free radical scavenging abilities on melanoma cells.
Juang LJ; Gao XY; Mai ST; Lee CH; Lee MC; Yao CL
J Cosmet Dermatol; 2019 Feb; 18(1):322-332. PubMed ID: 29460390
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of Low-Dose Doxorubicin Cytotoxicity by Affecting P-Glycoprotein through Caryophyllane Sesquiterpenes in HepG2 Cells: an in Vitro and in Silico Study.
Di Sotto A; Irannejad H; Eufemi M; Mancinelli R; Abete L; Mammola CL; Altieri F; Mazzanti G; Di Giacomo S
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963614
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anticancer activity and circumvention of resistance mechanisms by novel polymeric/ phospholipidic nanocarriers of doxorubicin.
Senkiv Y; Riabtseva A; Heffeter P; Boiko N; Kowol CR; Jungwith U; Shlyakhtina Y; Garasevych SG; Mitina N; Berger W; Zaichenko A; Stoika R
J Biomed Nanotechnol; 2014 Jul; 10(7):1369-81. PubMed ID: 24804557
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity.
Alimoradi H; Greish K; Barzegar-Fallah A; Alshaibani L; Pittalà V
Int J Nanomedicine; 2018; 13():7771-7787. PubMed ID: 30538458
[TBL] [Abstract][Full Text] [Related]
18. The impact of sesquiterpenes β-caryophyllene oxide and trans-nerolidol on xenobiotic-metabolizing enzymes in mice in vivo.
Lněničková K; Svobodová H; Skálová L; Ambrož M; Novák F; Matoušková P
Xenobiotica; 2018 Nov; 48(11):1089-1097. PubMed ID: 29098926
[TBL] [Abstract][Full Text] [Related]
19. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.
Xu HB; Li L; Fu J; Mao XP; Xu LZ
Pharmacology; 2012; 89(5-6):303-12. PubMed ID: 22573000
[TBL] [Abstract][Full Text] [Related]
20. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
